Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm ...

Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...

Cantor Fitzgerald analyst Kristen Kluska initiated coverage of Supernus (SUPN) with an Overweight rating and $57 price target Don't Miss Our ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares are ...

Cantor Fitzgerald reiterated their overweight rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research report released on Monday,Benzinga reports. Cantor Fitzgerald currently has a ...

Rivian reports 14,183 EV deliveries in December quarter, analysts react. Cantor Fitzgerald reiterates Overweight with $13 ...

Rivian Automotive (NASDAQ:RIVN – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts ...

Ladenburg Thalmann has recently reduced SoundHound AI Inc (SOUN) stock to Neutral rating, as announced on November 13, 2024, according to Finviz. Earlier, on August 9, 2024, Cantor Fitzgerald had ...

Cantor Fitzgerald has recently raised Cameco Corp (CCJ) stock to Overweight rating, as announced on July 31, 2024, according to Finviz. Earlier, on April 1, 2024, Goldman had initiated the stock to ...

The stock market is taking a breather after a relentless run, but opportunities still abound, according to some on Wall ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares after the company announced results from the Phase 3 ...